EUVIMEDEUVIMED entdecken
Crossref

Study on the role of MYCN in retinoblastoma by inhibiting p53 and activating wnt/βcatenin/Fra‐1 signaling pathway by reducing DKK3

Xinke Chen, Lijuan Ouyang, Ning Ke, Lianhong Pi, Xiyuan Zhou iD

Drug Development Research · 2024

DOI: 10.1002/ddr.22222 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, 2024. Verfasst von Xinke Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, M…. Hauptthemen laut MEDLINE: N-Myc Proto-Oncogene Protein, Retinoblastoma, Tumor Suppressor Protein p53, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Retinoblastoma (RB) is a pediatric malignancy, typically diagnosed at birth or during early childhood. The pathogenesis of RB is marked by the amplification of the Basic Helix–Loop–Helix (BHLH) Transcription Factor MYCN, which serves as a transcriptional regulator capable of binding to Dickkopf 3 (DKK3). However, the precise role of DKK3 in the malignant progression of RB cells caused by MYCN remains elusive. In the present study, the expression of MYCN was either overexpressed or interfered in RB cells. Subsequently, the expression level of DKK3 was assessed through quantitative real‐time polymerase chain reaction and western blot analysis. Cell proliferation was evaluated using the Cell Counting Kit‐8 assay and 5‐ethynyl‐2′‐deoxyuridine staining, while cell cycle progression and apoptosis were analyzed by flow cytometry and western blot analysis, respectively. Additionally, the expression of proteins involved in the Wnt/β‐catenin/Fra‐1/p53 signaling pathway was evaluated via western blot analysis. To gain further insights, Wnt agonists and the P53 inhibitor PFT‐α were introduced into exploration. The current investigation revealed a negative correlation between the expression levels of MYCN and DKK3 in RB cells. Additionally, DKK3 overexpression inhibited cell proliferation, promoted cell apoptosis, and arrested cell cycle in RB cells with high expression of MYCN. Moreover, enhanced DKK3 expression inhibited proliferation, promoted cell cycle arrest and apoptosis of RB cells by modulating the wnt/βcatenin/Fra‐1/p53 signaling pathway. Furthermore, in vivo experiments revealed that overexpression of DKK3 inhibits the growth of RB tumors. Collectively, our findings elucidate that MYCN stimulates the Wnt/β‐catenin/Fra‐1 pathway by suppressing DKK3 expression, ultimately suppressing p53 activity and contributing to malignant progression of RB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

N-Myc Proto-Oncogene ProteinRetinoblastomaTumor Suppressor Protein p53Adaptor Proteins, Signal TransducingWnt Signaling PathwayCell ProliferationHumansCell Line, TumorAnimalsMiceApoptosisIntercellular Signaling Peptides and ProteinsMice, Nudebeta Catenin

Stichwörter der Autor:innen

DKK3MYCNmalignant progressionretinoblastomawnt/βcatenin/Fra‐1

Substanzen

N-Myc Proto-Oncogene ProteinDKK3 protein, humanTumor Suppressor Protein p53MYCN protein, humanAdaptor Proteins, Signal TransducingIntercellular Signaling Peptides and ProteinsTP53 protein, humanbeta Catenin

Autor:innen und Institutionen

  • Department of Ophthalmology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders…
  • The Second Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, Chongqing, China.

ORCID-Profile: Xiyuan Zhou

Zitieren

APA

Chen, X., Ouyang, L., Ke, N., Pi, L., & Zhou, X. (2024). Study on the role of MYCN in retinoblastoma by inhibiting p53 and activating wnt/βcatenin/Fra‐1 signaling pathway by reducing DKK3. Drug Development Research. https://doi.org/10.1002/ddr.22222

Vancouver

Chen X, Ouyang L, Ke N, Pi L, Zhou X. Study on the role of MYCN in retinoblastoma by inhibiting p53 and activating wnt/βcatenin/Fra‐1 signaling pathway by reducing DKK3. Drug Development Research. 2024. doi:10.1002/ddr.22222

BibTeX
@article{Chen2024,
  author = {Chen, Xinke and Ouyang, Lijuan and Ke, Ning and Pi, Lianhong and Zhou, Xiyuan},
  title = {Study on the role of MYCN in retinoblastoma by inhibiting p53 and activating wnt/βcatenin/Fra‐1 signaling pathway by reducing DKK3},
  journal = {Drug Development Research},
  year = {2024},
  doi = {10.1002/ddr.22222}
}
Kostenlos starten →